Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2006 Sep;51(9):1516-24. Epub 2006 Aug 22.

PMID:
16927148
[PubMed - indexed for MEDLINE]
2.

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2010 Apr;55(4):1066-78. doi: 10.1007/s10620-009-0846-9. Epub 2009 Jun 10.

PMID:
19513841
[PubMed - indexed for MEDLINE]
3.

The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.

Saibeni S, Virgilio T, D'Incà R, Spina L, Bortoli A, Paccagnella M, Peli M, Sablich R, Meucci G, Colombo E, Benedetti G, Girelli CM, Casella G, Grasso G, de Franchis R, Vecchi M.

Dig Liver Dis. 2008 Oct;40(10):814-20. doi: 10.1016/j.dld.2008.03.016. Epub 2008 May 13.

PMID:
18479986
[PubMed - indexed for MEDLINE]
4.

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.

Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.

Am J Gastroenterol. 2006 May;101(5):1048-56.

PMID:
16573777
[PubMed - indexed for MEDLINE]
5.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.

Am J Gastroenterol. 2009 Nov;104(11):2760-7. doi: 10.1038/ajg.2009.410. Epub 2009 Jul 21.

PMID:
19623172
[PubMed - indexed for MEDLINE]
6.

Bone density improves with disease remission in patients with inflammatory bowel disease.

Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP.

Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1267-73.

PMID:
14624148
[PubMed - indexed for MEDLINE]
7.

Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.

Pozler O, Maly J, Bonova O, Dedek P, Frühauf P, Havlickova A, Janatova T, Jimramovsky F, Klimova L, Klusacek D, Kocourkova D, Kolek A, Kotalova R, Marx D, Nevoral J, Petro R, Petru O, Plasilova I, Seidl Z, Sekyrova I, Semendak N, Schreierova I, Stanek J, Sykora J, Sulakova A, Toukalkova L, Travnickova R, Volf V, Zahradnicek L, Zenisková I.

J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):186-9.

PMID:
16456413
[PubMed - indexed for MEDLINE]
10.

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.

Domènech E, Nos P, Papo M, López-San Román A, Garcia-Planella E, Gassull MA.

Scand J Gastroenterol. 2005 Jan;40(1):52-5.

PMID:
15841714
[PubMed - indexed for MEDLINE]
11.

Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.

Mossop H, Davies P, Murphy MS.

J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):123-9. doi: 10.1097/MPG.0b013e318156a834.

PMID:
18664861
[PubMed - indexed for MEDLINE]
12.

Current therapy of inflammatory bowel disease in children.

Rufo PA, Bousvaros A.

Paediatr Drugs. 2006;8(5):279-302. Review.

PMID:
17037946
[PubMed - indexed for MEDLINE]
13.

Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?

Campbell S, Ghosh S.

Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1073-6.

PMID:
11564958
[PubMed - indexed for MEDLINE]
14.

Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.

Vijverman A, Piront P, Belaiche J, Louis E.

Acta Gastroenterol Belg. 2006 Jan-Mar;69(1):1-4.

PMID:
16673554
[PubMed - indexed for MEDLINE]
15.

[Azathioprine in inflammatory bowel disease].

Leite S, Ribeiro JM, Lima SC, Barroso S, Cotter J.

Acta Med Port. 2009 Jan-Feb;22(1):33-40. Epub 2009 Mar 25. Portuguese.

PMID:
19341591
[PubMed - indexed for MEDLINE]
Free Article
16.

Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease.

Nguyen GC, Harris ML, Dassopoulos T.

Curr Gastroenterol Rep. 2006 Dec;8(6):499-505. Review.

PMID:
17105689
[PubMed - indexed for MEDLINE]
17.

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.

Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.

Aliment Pharmacol Ther. 2005 Apr 1;21(7):829-39.

PMID:
15801918
[PubMed - indexed for MEDLINE]
Free Article
18.

Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.

Campbell S, Ghosh S.

Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1297-301.

PMID:
11692054
[PubMed - indexed for MEDLINE]
19.

Experience with the use of low-dose methotrexate for inflammatory bowel disease.

Soon SY, Ansari A, Yaneza M, Raoof S, Hirst J, Sanderson JD.

Eur J Gastroenterol Hepatol. 2004 Sep;16(9):921-6.

PMID:
15316419
[PubMed - indexed for MEDLINE]
20.

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.

Fraser AG, Orchard TR, Jewell DP.

Gut. 2002 Apr;50(4):485-9.

PMID:
11889067
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk